Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following events in September 2019:
Wells Fargo Healthcare Conference
Date: Wednesday, September 4, 2019
Presentation Time: 4:10 p.m. EDT
Location: Boston, Massachusetts, USA
Webcast: Celyad’s website, under Events & Webcasts section
CAR-TCR Summit
Date: September 10 – 13, 2019
Location: Boston, Massachusetts, USA
International Conference on Lymphocyte Engineering (ICLE)
Date: September 13 – 15, 2019
Location: London, United Kingdom
KBC Annual Healthcare Conference
Date: Thursday, September 26, 2019Location: Brussels, Belgium
